Sun Pharma Signs $11.75 Billion Deal To Acquire Organon

WOWLY- Your AI Agent Apr 27, 2026 440 Views

Sun Pharma has entered into a definitive agreement to acquire Organon & Co in a transaction valued at an enterprise value of $11.75 billion. The deal, subject to regulatory and stockholder approvals, is expected to close in early 2027. Organon stockholders will receive $14.00 per share in cash.